• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

30株杜克雷嗜血杆菌对包括6种头孢菌素在内的几种抗生素的体外敏感性

In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins.

作者信息

Sanson-Le Pors M J, Casin I, Ortenberg M, Perol Y

出版信息

J Antimicrob Chemother. 1983 Mar;11(3):271-80. doi: 10.1093/jac/11.3.271.

DOI:10.1093/jac/11.3.271
PMID:6601649
Abstract

We have studied the in-vitro susceptibility of 30 strains of Haemophilus ducreyi to 22 antibacterial agents. Twenty-seven strains produced a beta-lactamase that had an isoelectric point similar to the isoelectric point of the TEM 1 type beta-lactamase produced by pSF 2124. Except for cefamandole, the 30 strains had similar susceptibilities to the different cephalosporins, cefotaxime being the most active compound. Twenty-two isolates were resistant to tetracycline and doxycycline; minimal inhibitory concentration (MIC) of minocycline was 4 mg/l for all the strains. One isolate was resistant to chloramphenicol (MIC = 16 mg/l). All strains were relatively resistant to colistin and nalidixic acid, and susceptible to streptomycin, kanamycin, gentamicin, erythromycin, rifampicin and vancomycin.

摘要

我们研究了30株杜克雷嗜血杆菌对22种抗菌剂的体外敏感性。27株菌株产生了一种β-内酰胺酶,其等电点与由pSF 2124产生的TEM 1型β-内酰胺酶的等电点相似。除头孢孟多外,这30株菌株对不同头孢菌素的敏感性相似,头孢噻肟是最具活性的化合物。22株分离株对四环素和强力霉素耐药;所有菌株对米诺环素的最低抑菌浓度(MIC)为4mg/l。1株分离株对氯霉素耐药(MIC = 16mg/l)。所有菌株对黏菌素和萘啶酸相对耐药,对链霉素、卡那霉素、庆大霉素、红霉素、利福平和万古霉素敏感。

相似文献

1
In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins.30株杜克雷嗜血杆菌对包括6种头孢菌素在内的几种抗生素的体外敏感性
J Antimicrob Chemother. 1983 Mar;11(3):271-80. doi: 10.1093/jac/11.3.271.
2
Antimicrobial susceptibility of Haemophilus ducreyi.杜克雷嗜血杆菌的抗菌药敏性。
Antimicrob Agents Chemother. 1978 Apr;13(4):608-12. doi: 10.1128/AAC.13.4.608.
3
Comparison of antimicrobial susceptibility patterns of fifty-seven strains of Haemophilus ducreyi isolated in Amsterdam from 1978 to 1985.
J Antimicrob Chemother. 1987 Feb;19(2):187-91. doi: 10.1093/jac/19.2.187.
4
Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi.非洲南部杜克雷嗜血杆菌分离株的抗菌药敏性
Antimicrob Agents Chemother. 1988 Sep;32(9):1458-60. doi: 10.1128/AAC.32.9.1458.
5
Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.对第三代头孢菌素耐药的革兰氏阴性杆菌:β-内酰胺酶特性及对Sch 34343的敏感性
J Antimicrob Chemother. 1985 Jun;15 Suppl C:119-32. doi: 10.1093/jac/15.suppl_c.119.
6
Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.多种肠胃外和口服抗菌剂对地方性杜克雷嗜血杆菌的体外活性比较。
Antimicrob Agents Chemother. 1993 Sep;37(9):1986-8. doi: 10.1128/AAC.37.9.1986.
7
Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.美国杜克雷嗜血杆菌分离株的体外抗菌药敏性与β-内酰胺酶质粒含量之间的相关性
Antimicrob Agents Chemother. 1992 Aug;36(8):1639-43. doi: 10.1128/AAC.36.8.1639.
8
Drug resistance of Haemophilus ducreyi.杜克雷嗜血杆菌的耐药性
Southeast Asian J Trop Med Public Health. 1990 Jun;21(2):185-93.
9
A comparison of the in vitro activity of rosamicin, erythromycin, clindamycin, metroidazole and ornidazole against Haemophilus ducreyi, including beta-lactamase producing strains.罗沙米星、红霉素、克林霉素、甲硝唑和奥硝唑对杜克雷嗜血杆菌(包括产β-内酰胺酶菌株)的体外活性比较。
J Antimicrob Chemother. 1979 Nov;5(6):731-4. doi: 10.1093/jac/5.6.731.
10
Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.在约翰内斯堡分离出的103株杜克雷嗜血杆菌的抗菌药敏性
Antimicrob Agents Chemother. 1982 Oct;22(4):686-8. doi: 10.1128/AAC.22.4.686.

引用本文的文献

1
In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.来自泰国和美国的杜克嗜血杆菌分离株对目前推荐的以及新型软下疳治疗药物的体外敏感性。
Antimicrob Agents Chemother. 1993 Jul;37(7):1552-5. doi: 10.1128/AAC.37.7.1552.
2
Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.多种肠胃外和口服抗菌剂对地方性杜克雷嗜血杆菌的体外活性比较。
Antimicrob Agents Chemother. 1993 Sep;37(9):1986-8. doi: 10.1128/AAC.37.9.1986.
3
Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi.
非洲南部杜克雷嗜血杆菌分离株的抗菌药敏性
Antimicrob Agents Chemother. 1988 Sep;32(9):1458-60. doi: 10.1128/AAC.32.9.1458.
4
Plasmid-mediated aminoglycoside phosphotransferases in Haemophilus ducreyi.杜克雷嗜血杆菌中质粒介导的氨基糖苷磷酸转移酶
Antimicrob Agents Chemother. 1985 Aug;28(2):315-9. doi: 10.1128/AAC.28.2.315.
5
Biotypes, serotypes, and susceptibility to antibiotics of 60 Haemophilus influenzae strains from genitourinary tracts.来自泌尿生殖道的60株流感嗜血杆菌的生物型、血清型及抗生素敏感性
Genitourin Med. 1988 Jun;64(3):185-8. doi: 10.1136/sti.64.3.185.
6
In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.壮观霉素类似物U-63366、新型大环内酯类抗生素罗红霉素(RU 28965)以及五种喹诺酮衍生物对杜克雷嗜血杆菌的体外活性。
Antimicrob Agents Chemother. 1986 Sep;30(3):512-3. doi: 10.1128/AAC.30.3.512.
7
Antimicrobial susceptibility of Haemophilus ducreyi.杜克雷嗜血杆菌的抗菌药敏性。
Antimicrob Agents Chemother. 1990 Jul;34(7):1303-7. doi: 10.1128/AAC.34.7.1303.
8
Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.阿莫西林/克拉维酸:抗菌活性、药代动力学特性及治疗用途的最新进展
Drugs. 1990 Feb;39(2):264-307. doi: 10.2165/00003495-199039020-00008.
9
Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.美国杜克雷嗜血杆菌分离株的体外抗菌药敏性与β-内酰胺酶质粒含量之间的相关性
Antimicrob Agents Chemother. 1992 Aug;36(8):1639-43. doi: 10.1128/AAC.36.8.1639.